A southern Taiwan-based National Cheng Kung University research team has discovered that rapamycin, a drug that acts as an autophagy activator, is a possible treatment to alleviating frontotemporal lobar degeneration, one of the main causes of dementia for which there currently is no effective treatment.
BusinessWire